Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Fulvestrant
Related studies linked through entity extraction aliases.
Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
- Status
- COMPLETED
- Phase
- PHASE3
Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.
- Status
- COMPLETED
- Phase
- PHASE2
Faslodex 500mg Multiple Dose Tolerability Study in BC Patients
- Status
- COMPLETED
- Phase
- PHASE1
Faslodex Advanced Breast Cancer Local Chinese Study
- Status
- COMPLETED
- Phase
- PHASE3
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg
- Status
- COMPLETED
- Phase
- PHASE2
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg
- Status
- COMPLETED
- Phase
- PHASE2
Faslodex in McCune-Albright Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Study of Faslodex +/- Concomitant Arimidex v Exemestane Following Progression on Non-steroidal Aromatase Inhibitors
- Status
- COMPLETED
- Phase
- PHASE3
Fulvestrant in Treating Patients With Advanced Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Fulvestrant in Treating Patients With Recurrent Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2